Publisher's Note

The December 1, 2005, article by Burtness et al titled, “Phase III Randomized Trial of Cisplatin Plus Placebo Compared With Cisplatin Plus Cetuximab in Metastatic/Recurrent Head and Neck Cancer: An Eastern Cooperative Oncology Group Study” (J Clin Oncol 23:8646-8654, 2005) was published online on November 28, 2005, with incorrect information.

In the Abstract, in the second-to-last sentence of the Results section, the values for objective response rate were interchanged. Whereas 10% was given for arm A and 26% for arm B, it should have read 26% for arm A and 10% for arm B.

In Figure 1, the median values were interchanged. Whereas 2.7 was given for the C225 arm and 4.2 for the placebo arm, it should have read 4.2 for the C225 arm and 2.7 for the placebo arm.

In Figure 2, the median values were interchanged. Whereas 8 was given for the C225 arm and 9.2 for the placebo arm, it should have read 9.2 for the C225 arm and 8 for the placebo arm.

These corrections were made on December 12, 2005, and January 13, 2006.